Healthcare -
Biotechnology - NASDAQ - DK
$ 156.58
2.25 %
$ 9.37 B
Market Cap
-22.86
P/E
Price Target
Average
24.17%
Revenue Forecast
Estimate
69.54%
EBIT
Estimate
--79.78%
Net Income
Estimate
47.95%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ascendis Pharma A/S
Wall Street analysts predict an average 1-year price target for ASND of $194 , with forecasts ranging from
a
low of
$140 to a high of $289 .
ASND Lowest Price Target
Wall Street Target
140 USD
-10.59%
ASND Average Price Target
Wall Street Target
194 USD
24.17%
ASND Highest Price Target
Wall Street Target
289 USD
84.57%
REVENUE FORECAST
Revenue Forecast Chart ASND
EBIT FORECAST
EBIT Forecast Chart ASND
NET INCOME FORECAST
Net Income Chart ASND